Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio
"Imbio is very excited to join forces with 4DMedical to create the leading lung imaging AI suite in the market, combining 4DMedical's functional analysis with Imbio's anatomical and tissue analysis. Together we can help clinicians around the globe detect disease earlier, make more robust diagnosis, and drive more informed and confident decision-making for better patient care," said Dave Hannes, CEO at Imbio.